Imaging technologies for preclinical models of bone and joint disorders

Preclinical models for musculoskeletal disorders are critical for understanding the pathogenesis of bone and joint disorders in humans and the development of effective therapies. The assessment of these models primarily relies on morphological analysis which remains time consuming and costly, requir...

Full description

Bibliographic Details
Main Authors: Tremoleda, J, Khalil, M, Gompels, L, Wylezinska-Arridge, M, Vincent, T, Gsell, W
Format: Journal article
Language:English
Published: 2011
_version_ 1797082345031860224
author Tremoleda, J
Khalil, M
Gompels, L
Wylezinska-Arridge, M
Vincent, T
Gsell, W
author_facet Tremoleda, J
Khalil, M
Gompels, L
Wylezinska-Arridge, M
Vincent, T
Gsell, W
author_sort Tremoleda, J
collection OXFORD
description Preclinical models for musculoskeletal disorders are critical for understanding the pathogenesis of bone and joint disorders in humans and the development of effective therapies. The assessment of these models primarily relies on morphological analysis which remains time consuming and costly, requiring large numbers of animals to be tested through different stages of the disease. The implementation of preclinical imaging represents a keystone in the refinement of animal models allowing longitudinal studies and enabling a powerful, non-invasive and clinically translatable way for monitoring disease progression in real time. Our aim is to highlight examples that demonstrate the advantages and limitations of different imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and optical imaging. All of which are in current use in preclinical skeletal research. MRI can provide high resolution of soft tissue structures, but imaging requires comparatively long acquisition times; hence, animals require long-term anaesthesia. CT is extensively used in bone and joint disorders providing excellent spatial resolution and good contrast for bone imaging. Despite its excellent structural assessment of mineralized structures, CT does not provide in vivo functional information of ongoing biological processes. Nuclear medicine is a very promising tool for investigating functional and molecular processes in vivo with new tracers becoming available as biomarkers. The combined use of imaging modalities also holds significant potential for the assessment of disease pathogenesis in animal models of musculoskeletal disorders, minimising the use of conventional invasive methods and animal redundancy. © 2011 Tremoleda et al.
first_indexed 2024-03-07T01:26:51Z
format Journal article
id oxford-uuid:9247a249-8c86-4b5c-a593-60ffc47f3027
institution University of Oxford
language English
last_indexed 2024-03-07T01:26:51Z
publishDate 2011
record_format dspace
spelling oxford-uuid:9247a249-8c86-4b5c-a593-60ffc47f30272022-03-26T23:24:18ZImaging technologies for preclinical models of bone and joint disordersJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9247a249-8c86-4b5c-a593-60ffc47f3027EnglishSymplectic Elements at Oxford2011Tremoleda, JKhalil, MGompels, LWylezinska-Arridge, MVincent, TGsell, WPreclinical models for musculoskeletal disorders are critical for understanding the pathogenesis of bone and joint disorders in humans and the development of effective therapies. The assessment of these models primarily relies on morphological analysis which remains time consuming and costly, requiring large numbers of animals to be tested through different stages of the disease. The implementation of preclinical imaging represents a keystone in the refinement of animal models allowing longitudinal studies and enabling a powerful, non-invasive and clinically translatable way for monitoring disease progression in real time. Our aim is to highlight examples that demonstrate the advantages and limitations of different imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and optical imaging. All of which are in current use in preclinical skeletal research. MRI can provide high resolution of soft tissue structures, but imaging requires comparatively long acquisition times; hence, animals require long-term anaesthesia. CT is extensively used in bone and joint disorders providing excellent spatial resolution and good contrast for bone imaging. Despite its excellent structural assessment of mineralized structures, CT does not provide in vivo functional information of ongoing biological processes. Nuclear medicine is a very promising tool for investigating functional and molecular processes in vivo with new tracers becoming available as biomarkers. The combined use of imaging modalities also holds significant potential for the assessment of disease pathogenesis in animal models of musculoskeletal disorders, minimising the use of conventional invasive methods and animal redundancy. © 2011 Tremoleda et al.
spellingShingle Tremoleda, J
Khalil, M
Gompels, L
Wylezinska-Arridge, M
Vincent, T
Gsell, W
Imaging technologies for preclinical models of bone and joint disorders
title Imaging technologies for preclinical models of bone and joint disorders
title_full Imaging technologies for preclinical models of bone and joint disorders
title_fullStr Imaging technologies for preclinical models of bone and joint disorders
title_full_unstemmed Imaging technologies for preclinical models of bone and joint disorders
title_short Imaging technologies for preclinical models of bone and joint disorders
title_sort imaging technologies for preclinical models of bone and joint disorders
work_keys_str_mv AT tremoledaj imagingtechnologiesforpreclinicalmodelsofboneandjointdisorders
AT khalilm imagingtechnologiesforpreclinicalmodelsofboneandjointdisorders
AT gompelsl imagingtechnologiesforpreclinicalmodelsofboneandjointdisorders
AT wylezinskaarridgem imagingtechnologiesforpreclinicalmodelsofboneandjointdisorders
AT vincentt imagingtechnologiesforpreclinicalmodelsofboneandjointdisorders
AT gsellw imagingtechnologiesforpreclinicalmodelsofboneandjointdisorders